These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 37873295)

  • 21. 32-Phosphorus selectively delivered by listeria to pancreatic cancer demonstrates a strong therapeutic effect.
    Chandra D; Selvanesan BC; Yuan Z; Libutti SK; Koba W; Beck A; Zhu K; Casadevall A; Dadachova E; Gravekamp C
    Oncotarget; 2017 Mar; 8(13):20729-20740. PubMed ID: 28186976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced antitumoral activity of oncolytic herpes simplex virus with gemcitabine using colorectal tumor models.
    Esaki S; Goshima F; Kimura H; Murakami S; Nishiyama Y
    Int J Cancer; 2013 Apr; 132(7):1592-601. PubMed ID: 22949155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visualization of granzyme B-expressing CD8 T cells during primary and secondary immune responses to Listeria monocytogenes.
    Mouchacca P; Chasson L; Frick M; Foray C; Schmitt-Verhulst AM; Boyer C
    Immunology; 2015 May; 145(1):24-33. PubMed ID: 25367158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gemcitabine loaded microbubbles for targeted chemo-sonodynamic therapy of pancreatic cancer.
    Nesbitt H; Sheng Y; Kamila S; Logan K; Thomas K; Callan B; Taylor MA; Love M; O'Rourke D; Kelly P; Beguin E; Stride E; McHale AP; Callan JF
    J Control Release; 2018 Jun; 279():8-16. PubMed ID: 29653222
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Ding YD; Shu LZ; He RS; Chen KY; Deng YJ; Zhou ZB; Xiong Y; Deng H
    Front Immunol; 2023; 14():1278011. PubMed ID: 37868979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Priming and activation of human ovarian and breast cancer-specific CD8+ T cells by polyvalent Listeria monocytogenes-based vaccines.
    Sinnathamby G; Lauer P; Zerfass J; Hanson B; Karabudak A; Krakover J; Secord AA; Clay TM; Morse MA; Dubensky TW; Brockstedt DG; Philip R; Giedlin M
    J Immunother; 2009 Oct; 32(8):856-69. PubMed ID: 19752748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-pancreatic tumor efficacy of a Listeria-based, Annexin A2-targeting immunotherapy in combination with anti-PD-1 antibodies.
    Kim VM; Blair AB; Lauer P; Foley K; Che X; Soares K; Xia T; Muth ST; Kleponis J; Armstrong TD; Wolfgang CL; Jaffee EM; Brockstedt D; Zheng L
    J Immunother Cancer; 2019 May; 7(1):132. PubMed ID: 31113479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gemcitabine enhances antitumor efficacy of recombinant lipoimmunogen-based immunotherapy.
    Chang LS; Yan WL; Chang YW; Yeh YC; Chen HW; Leng CH; Liu SJ
    Oncoimmunology; 2016 Mar; 5(3):e1095433. PubMed ID: 27141356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant
    Deng W; Lira V; Hudson TE; Lemmens EE; Hanson WG; Flores R; Barajas G; Katibah GE; Desbien AL; Lauer P; Leong ML; Portnoy DA; Dubensky TW
    Proc Natl Acad Sci U S A; 2018 Aug; 115(32):8179-8184. PubMed ID: 30038013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attenuated
    Lizotte PH; Baird JR; Stevens CA; Lauer P; Green WR; Brockstedt DG; Fiering SN
    Oncoimmunology; 2014; 3():e28926. PubMed ID: 25083323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in peripheral blood of non-small cell lung carcinoma patients responding to atezolizumab treatment.
    Fehlings M; Jhunjhunwala S; Kowanetz M; O'Gorman WE; Hegde PS; Sumatoh H; Lee BH; Nardin A; Becht E; Flynn S; Ballinger M; Newell EW; Yadav M
    J Immunother Cancer; 2019 Sep; 7(1):249. PubMed ID: 31511069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ovarian granulosa cell tumor characterization identifies FOXL2 as an immunotherapeutic target.
    Pierini S; Tanyi JL; Simpkins F; George E; Uribe-Herranz M; Drapkin R; Burger R; Morgan MA; Facciabene A
    JCI Insight; 2020 Aug; 5(16):. PubMed ID: 32814714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice.
    Meng H; Wang M; Liu H; Liu X; Situ A; Wu B; Ji Z; Chang CH; Nel AE
    ACS Nano; 2015; 9(4):3540-57. PubMed ID: 25776964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PD1-CD28 Fusion Protein Enables CD4+ T Cell Help for Adoptive T Cell Therapy in Models of Pancreatic Cancer and Non-hodgkin Lymphoma.
    Rataj F; Kraus FBT; Chaloupka M; Grassmann S; Heise C; Cadilha BL; Duewell P; Endres S; Kobold S
    Front Immunol; 2018; 9():1955. PubMed ID: 30214445
    [No Abstract]   [Full Text] [Related]  

  • 35. Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell'Italia Meridionale.
    Colucci G; Giuliani F; Gebbia V; Biglietto M; Rabitti P; Uomo G; Cigolari S; Testa A; Maiello E; Lopez M
    Cancer; 2002 Feb; 94(4):902-10. PubMed ID: 11920457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gemcitabine-loaded RGD modified liposome for ovarian cancer: preparation, characterization and pharmacodynamic studies.
    Tang Z; Feng W; Yang Y; Wang Q
    Drug Des Devel Ther; 2019; 13():3281-3290. PubMed ID: 31571830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD44-targeting hydrophobic phosphorylated gemcitabine prodrug nanotherapeutics augment lung cancer therapy.
    Guo B; Wei J; Wang J; Sun Y; Yuan J; Zhong Z; Meng F
    Acta Biomater; 2022 Jun; 145():200-209. PubMed ID: 35430336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Caveolin-mediated cytosolic delivery of spike nanoparticle enhances antitumor immunity of neoantigen vaccine for hepatocellular carcinoma.
    Lin Z; Jiang C; Wang P; Chen Q; Wang B; Fu X; Liang Y; Zhang D; Zeng Y; Liu X
    Theranostics; 2023; 13(12):4166-4181. PubMed ID: 37554274
    [No Abstract]   [Full Text] [Related]  

  • 39. New Approaches for Immune Directed Treatment for Ovarian Cancer.
    Hardwick N; Frankel PH; Cristea M
    Curr Treat Options Oncol; 2016 Mar; 17(3):14. PubMed ID: 26942589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD8+ T cell-mediated protection against an intracellular bacterium by perforin-dependent cytotoxicity.
    Kägi D; Ledermann B; Bürki K; Hengartner H; Zinkernagel RM
    Eur J Immunol; 1994 Dec; 24(12):3068-72. PubMed ID: 7805735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.